| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 57.83B | 64.18B | 55.26B | 52.99B | 52.35B | 49.41B |
| Gross Profit | 14.93B | 15.88B | 13.80B | 13.72B | 14.76B | 15.27B |
| EBITDA | 8.59B | 9.71B | 8.10B | 7.58B | 7.98B | 7.87B |
| Net Income | 2.35B | 3.98B | 1.96B | 2.60B | 4.00B | 3.44B |
Balance Sheet | ||||||
| Total Assets | 86.74B | 97.88B | 90.11B | 88.29B | 78.10B | 76.56B |
| Cash, Cash Equivalents and Short-Term Investments | 15.37B | 20.85B | 18.57B | 26.47B | 19.53B | 21.47B |
| Total Debt | 30.69B | 28.65B | 30.06B | 35.73B | 26.28B | 28.95B |
| Total Liabilities | 57.04B | 60.93B | 58.93B | 59.52B | 51.66B | 53.45B |
| Stockholders Equity | 29.69B | 36.95B | 31.17B | 28.77B | 26.45B | 23.11B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 7.95B | 6.75B | 2.76B | 2.93B | 4.63B |
| Operating Cash Flow | 0.00 | 10.55B | 8.20B | 4.10B | 4.80B | 5.79B |
| Investing Cash Flow | 0.00 | -6.78B | -7.78B | -1.98B | -2.97B | -5.56B |
| Financing Cash Flow | 0.00 | -3.98B | -8.31B | 4.75B | -3.82B | -720.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥15.84B | 7.21 | ― | 3.81% | 7.75% | 71.62% | |
76 Outperform | ¥32.97B | 17.48 | ― | 5.00% | 2.53% | -6.30% | |
76 Outperform | ¥42.16B | 15.10 | ― | 2.56% | 7.38% | 4.61% | |
75 Outperform | ¥42.56B | 6.09 | ― | 2.28% | 7.47% | 12.35% | |
71 Outperform | ¥36.81B | 17.68 | ― | 3.55% | 3.13% | 6.72% | |
65 Neutral | ¥67.45B | 22.26 | ― | 3.98% | 16.16% | 103.63% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% |